 the recent VQI
report by Hicks et al showed transfemoral CAS was not
associated with a signiﬁcant difference in stroke and
death when compared with CEA among low-risk, propensity-matched patients (HR, 1.49; 95% CI, 0.76-2.90;
P ¼ .24).200
Transcarotid artery revascularization. The 30-day incidence of stroke and